A summary of what the latest Spending Review means for our community
Parkinson’s UK is joining forces with US charity The Michael J. Fox Foundation and biopharma company Neurolixis to fund a £1.5m clinical trial of an exciting new drug to combat dyskinesia in people with Parkinson’s.
Parkinson's UK is launching a grant scheme with Sport Parkinson’s CIC to revolutionise the sport and exercise world for people living with Parkinson's.
After 15 years leading the charity, Steve Ford is saying a fond farewell to Parkinson's UK at the end of January 2021. He'll then start his search for a new challenge.
Find out about a parliamentary committee we gave evidence to about the impact of coronavirus on people with Parkinson’s
On 17 and 18 October, friends and families picked a partner from within their household or support bubble to take on this exciting Three-Legged challenge.
We're funding a new research study into a possible treatment for hallucinations in Parkinson's.
Parkinson's UK supporter Paul Mayhew-Archer reflects on his MBE in the honours list.
Join Parkinson's UK Scotland on their first ever online Younger Parkinson's event!
Researchers in the US have uncovered a link between long-term exposure to pollution and deterioration in health conditions. This includes Parkinson's and Alzheimer's.